Home / Knowledge Centre /
Technical Sheet

IXRS®3 Decentralised Trials Support

Decentralised Trials (DCT) – Direct to patient benefits

Direct to patient shipment functionality provides the ability for a site to register a visit with home delivery of investigational material. This type of protocol design can help with:

• Patient retention by lessening the burden of traveling to every dispensing site visit

• Prevention of wasted investigational material at sites with low or no enrollment

• Agility for a changing supply chain landscape

View Resource
Almac Logo

Almac Clinical Technologies

Almac Clinical Technologies is here to help the biopharmaceutical industry bring new therapies to those in need by empowering clinical trial sponsors to proactively manage sites, patients, and clinical trial supplies through our industry-leading Interactive Response Technology (IRT) and expert consultancy.

Almac Clinical Technologies is uniquely positioned to unlock new efficiencies in the clinical supply chain and to help achieve greater predictability in your projects and programs.

Our professionals are dedicated to delivering high-quality Interactive Response Technology (IRT) solutions, dependable professional services, and reliable customer service. Our expertise, energy, and commitment have earned us a reputation as a trusted ally in the drug development process.

Learn More

Download here instantly

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies